Long-term mortality among XXXX with @entity43 .

@entity1 @entity43 @entity5 @entity102 @entity204 @entity65
OBJECTIVES: @entity1 with solid @entity5 are at greatest risk for dying from their @entity5 in the five years following diagnosis. For most @entity5 , @entity204 from other @entity102 begin to exceed those from @entity5 at some point. As little is known about the causes of @entity204 among long-term survivors of @entity43 , we examined causes of @entity204 by years from diagnosis. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was used to identify @entity1 diagnosed with @entity43 between 1988 and 2012. We compared causes of @entity204 by stage, age, and interval time after diagnosis. RESULTS: A total of 67,385 @entity1 were identified. For stage I @entity5 , 13.6% (CI, 13.0-14.2%) died from @entity43 , 4.2% (CI, 3.8-4.5%) from @entity65 , 3.6% (CI, 3.3-3.9%) from other causes and 2.6% (CI, 2.4-2.9%) from other @entity5 ; @entity43 was the leading cause of @entity204 until 7years after diagnosis after which time @entity204 are more frequently due to other causes. For those with @entity5 , 67.8% (CI, 67.3-68.2%) died from @entity43 , 2.8% (CI, 2.6-2.9%) from other causes, 2.3% (CI, 2.2-2.4%) from @entity65 and 1.9% (CI, 1.7-2.0%) from other @entity5 ; @entity43 was the most frequent cause of @entity204 in years 1-15 after which time @entity204 were more commonly due to other causes. CONCLUSIONS: The probability of dying from @entity43 decreases with time. @entity43 remains the most common cause of @entity204 for 15years after diagnosis in @entity1 with @entity5 .
